Onconova Therapeutics, Inc. to Provide Corporate Update and Full Year 2018 Financial Results

NEXT STORY
Global Metagenomics Market to Garner $523 Million by 2024 at 16.8% CAGR, Says Allied Market Research
PREV STORY
Aravive Announces Retrospective Analysis Showing Increased GAS6 Levels Associated with Chemoresistance and Decreased Progression Free Survival in Ovarian Cancer
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Global Defibrillator Market to Expand at 5.3% CAGR and Reach USD 14,806.4 Million by 2026

author_avatar
NASDAQ Market News

Long-term functional data from Sarepta Therapeutics’ Most Advanced Gene Therapy Programs to be Presented at Upcoming Annual Congress of the World Muscle Society

author_avatar
NASDAQ Market News

FDA Approves Roche’s ENSPRYNG for Neuromyelitis Optica Spectrum Disorder (NMOSD)

author_avatar
NASDAQ Market News